Talpaz M - Search Results

1

Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.

Dorer DJ, Knickerbocker RK, Baccarani M, Cortes JE, Hochhaus A, Talpaz M, Haluska FG. Dorer DJ, et al. Among authors: talpaz m. Leuk Res. 2016 Sep;48:84-91. doi: 10.1016/j.leukres.2016.07.007. Epub 2016 Jul 22. Leuk Res. 2016. PMID: 27505637 Free article.

2

Identification of a complex formed between nuclear proteins and the transcriptional enhancer of interferon-inducible genes that is present in the peripheral blood myeloid cells of CML but not normal individuals.

Seong DC, Gottlieb K, Suh SP, Sims S, Talpaz M, Kantarjian H, Deisseroth A. Seong DC, et al. Among authors: talpaz m. J Interferon Res. 1992 Oct;12(5):323-7. doi: 10.1089/jir.1992.12.323. J Interferon Res. 1992. PMID: 1431311

3

Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.

Dhingra K, Kurzrock R, Kantarjian H, Baine R, Eastman PS, Ku S, Gutterman JU, Talpaz M. Dhingra K, et al. Among authors: talpaz m. Leukemia. 1992 Aug;6(8):754-60. Leukemia. 1992. PMID: 1640725

4

Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.

Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R. Dhingra K, et al. Among authors: talpaz m. Leukemia. 1991 Mar;5(3):191-5. Leukemia. 1991. PMID: 2013978

5

Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.

Estrov Z, Talpaz M, Chou TC, Kurzrock R, Blake M, Gutterman JU. Estrov Z, et al. Among authors: talpaz m. Leukemia. 1991 Feb;5(2):101-7. Leukemia. 1991. PMID: 2020193

6

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.

Cortes JE, Talpaz M, Cabanillas F, Seymour JF, Kurzrock R. Cortes JE, et al. Among authors: talpaz m. Blood. 1995 May 1;85(9):2516-20. Blood. 1995. PMID: 7537119 Free article.

7

Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.

Cortes JE, Talpaz M, Beran M, O'Brien SM, Rios MB, Stass S, Kantarjian HM. Cortes JE, et al. Among authors: talpaz m. Cancer. 1995 Jan 15;75(2):464-70. doi: 10.1002/1097-0142(19950115)75:2<464::aid-cncr2820750209>3.0.co;2-e. Cancer. 1995. PMID: 7812917

8

Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.

Kantarjian HM, Talpaz M. Kantarjian HM, et al. Among authors: talpaz m. Leuk Lymphoma. 1993;11 Suppl 1:169-74. doi: 10.3109/10428199309047881. Leuk Lymphoma. 1993. PMID: 8251891 Clinical Trial. No abstract available.

9

Interferon in chronic myeloid leukemia. A workshop report.

Griesshammer M, Hehlmann R, Hochhaus A, Talpaz M, Tura S, Stryckmans P, Allan NC, Tanzer J, Kolb HJ, Heimpel H. Griesshammer M, et al. Among authors: talpaz m. Ann Hematol. 1993 Aug;67(2):101-6. doi: 10.1007/BF01788134. Ann Hematol. 1993. PMID: 8347729 Review.

10

Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia.

Estrov Z, Kurzrock R, Talpaz M. Estrov Z, et al. Among authors: talpaz m. Leuk Lymphoma. 1993 Aug;10(6):407-18. doi: 10.3109/10428199309148197. Leuk Lymphoma. 1993. PMID: 8401177 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters